Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
+0.05%
1,104.65
+0.55
+0.05%
—1,104.101,103.921,108.751,097.16——
SIXC
Communications
SIXC
Communications
SIXC
+0.34%
606.21
+2.05
+0.34%
—604.16604.16610.19604.12——
SIXE
Energy
SIXE
Energy
SIXE
+0.02%
1,198.03
+0.19
+0.02%
—1,197.811,200.581,213.071,192.02——
SIXI
Industrials
SIXI
Industrials
SIXI
+0.02%
1,740.78
+0.37
+0.02%
—1,740.411,739.551,750.271,730.60——
SIXM
Financials
SIXM
Financials
SIXM
+0.77%
639.35
+4.91
+0.77%
—634.44633.13639.82633.01——
SIXR
Staples
SIXR
Staples
SIXR
-0.97%
832.71
-8.19
-0.97%
—840.90839.53841.73831.29——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0.73%
213.55
-1.58
-0.73%
—215.13215.13215.85213.59——
SIXT
Technology
SIXT
Technology
SIXT
-0.10%
3,225.35
-3.36
-0.10%
—3,228.713,225.623,228.273,198.95——
SIXU
Utilities
SIXU
Utilities
SIXU
+0.10%
936.83
+0.95
+0.10%
—935.87938.37942.00936.81——
SIXV
Health care
SIXV
Health care
SIXV
-0.32%
1,452.42
-4.70
-0.32%
—1,457.121,452.741,466.881,449.55——
SIXY
Discretionary
SIXY
Discretionary
SIXY
-0.58%
2,385.84
-14.00
-0.58%
—2,399.842,389.712,394.612,371.22——
ICUI:NASDAQ
ICU Medical Inc
$122.64
-1.75%
(-2.18) 1D
Apr 27, 3:42:28 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ICUI...
Open
$123.95
High
$126.19
Low
$121.48
Mkt. cap
3.06B
Avg. vol.
288.83K
Volume
201.90K
P/E ratio
4,172.68
52-wk high
$160.29
52-wk low
$107.00
EPS
$0.03
Beta
0.85
Shares outstanding
24.99M
No. of employees
13K
News stories
From sources across the web
Profile
ICU Medical, Inc. is a medical technology company based in San Clemente, California. ICU Medical products are designed to prevent bloodstream infections and protect healthcare workers from exposure to infectious diseases or hazardous drugs. ICU Medical product line includes intravenous therapy (IV) products, pumps, needle-free vascular access devices, custom infusion sets, closed system hazardous drug handling devices and systems, sensor catheters, needle-free closed blood sampling systems, and hemodynamic monitoring systems. ICU Medical products are designed to prevent bloodstream infections and protecting healthcare workers from exposure to infectious diseases or hazardous drugs. In addition, the company's IV medication compounding and delivery products are designed to improve medication and dosing accuracy and improve clinical workflows. In 2014 ICU Medical was named one of the 100 Most Trustworthy Companies in America by Forbes Magazine. Wikipedia
About ICU Medical Inc
CEOVivek Jain
Employees13K
Founded1984
HeadquartersSan Clemente, California, United States
SectorMedical device
Websiteicumed.com
Next call in 10 days
Thu, May 7, 4:30 PM
Fiscal Period
Q1 2026
Normalized EPS / Estimate
-/ (1.75 est.)USD
Revenue / Estimate
-/ (531.12M est.)USD
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance: upcoming earningsInsights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
604.70M
548.87M
536.99M
540.70M
Cost of goods sold
394.59M
340.80M
336.11M
337.72M
Cost of revenue
394.59M
340.80M
336.11M
337.72M
Research and development expenses
23.29M
21.87M
21.25M
21.09M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
157.23M
159.39M
152.77M
155.81M
Operating expense
180.52M
181.26M
174.02M
176.90M
Total operating expenses
575.12M
522.06M
510.13M
514.62M
Operating income
29.58M
26.80M
26.86M
26.09M
Other non operating income
209.00K
-68.00K
238.00K
-32.00K
EBT including unusual items
-10.91M
36.52M
-4.05M
-18.39M
EBT excluding unusual items
5.96M
10.97M
7.57M
4.75M
Income tax expense
4.57M
1.18M
-658.00K
-2.65M
Effective tax rate
-41.90%
3.23%
16.23%
14.43%
Other operating expenses
-
-
-
-
Net income
-15.48M
35.34M
-3.40M
-15.73M
Net profit margin
-2.56%
6.44%
-0.63%
-2.91%
Earnings per share
1.72
2.10
2.03
1.91
Interest and investment income
3.23M
2.52M
2.42M
2.14M
Interest expense
-25.26M
-23.06M
-22.23M
-22.78M
Net interest expenses
-22.03M
-20.55M
-19.81M
-20.64M
Depreciation and amortization charges
-
-
-
-
EBITDA
79.03M
76.47M
77.66M
76.92M
Gain or loss from assets sale
1.70M
-41.77M
-1.51M
2.69M
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer